The much-talked-about Retatrutide 20mg pen , a novel dual GIP and GLP-1 receptor , is currently being assessed by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK. General availability https://gorillasocialwork.com/story28203730/retatrutide-20mg-pen-uk-availability-updates